DiaMedica Therapeutics
DMAC
DMAC
39 hedge funds and large institutions have $14.9M invested in DiaMedica Therapeutics in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.18% more ownership
Funds ownership: 14.93% → 15.11% (+0.18%)
54% less call options, than puts
Call options by funds: $138K | Put options by funds: $302K
Holders
39
Holding in Top 10
–
Calls
$138K
Puts
$302K
Top Buyers
| 1 | +$3.84M | |
| 2 | +$485K | |
| 3 | +$373K | |
| 4 |
Two Sigma Investments
New York
|
+$248K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$111K |
Top Sellers
| 1 | -$478K | |
| 2 | -$380K | |
| 3 | -$171K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$38.5K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$36.2K |